Key facts
- This page summarizes DA32 Sponsor LLC's Form 4 filing for DA32 Life Science Tech Acquisition Corp..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Aug 2021, 19:37.
DA32 Sponsor LLC - 05 Aug 2021 Form 4 Insider Report for DA32 Life Science Tech Acquisition Corp.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 05 Aug 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2021, 19:37:09 UTC
- Prior SEC filing
- 03 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Henrikki Harsu, Attorney-in-Fact for DA32 Sponsor LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
DA32 Sponsor LLC filed Form 4 for DA32 Life Science Tech Acquisition Corp. on 09 Aug 2021.
Change
- Previous filing in this sequence was filed on 03 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DALS
transaction
Derivative
Class B Common Stock, par value $0.0001 per share
Other
- Transaction value
- $0
- Shares
- -701,250
- Change %
- -14%
- Price
- $0.000000
- Shares after
- 4,465,000
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 701,250
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
DA32 Sponsor LLC (the "Reporting Person") is the record holder of the securities reported herein. Deerfield Partners, L.P., ARCH Venture Fund XI, L.P. and Section 32 Fund 3, LP are the managing members of the Reporting Person, and share voting and investment discretion with respect to the common stock held of record by the Reporting Person. Each of the foregoing entities disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein.
Footnote F2
The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Shares" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date.
Footnote F3
On August 5, 2021, the Reporting Person forfeited 701,250 shares of Class B common stock to the Issuer for no consideration, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Person's control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the "IPO") disclosing all material information about the Issuer and the IPO.